Synergistic Antioxidant Effects of Molecular Hydrogen and Cold Atmospheric Plasma in Enhancing Mesenchymal Stem Cell Therapy.
Mikhail Yu Artamonov, Felix A Pyatakovich, Inessa A Minenko · Antioxidants (Basel, Switzerland) · 2024
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
This narrative review examined the available molecular-hydrogen literature. This review highlights the role of molecular hydrogen (H₂) and cold atmospheric plasma (CAP) as adjunct therapies to improve the effectiveness of MSC therapy. The reviewed evidence adds support for molecular hydrogen's therapeutic potential across the conditions, mechanisms, or outcomes examined.
What the Findings Mean
H2HUBB reviewed this publication as a synthesis of molecular-hydrogen research and summarizes the outcomes emphasized by the authors. This review highlights the role of molecular hydrogen (H₂) and cold atmospheric plasma (CAP) as adjunct therapies to improve the effectiveness of MSC therapy.
What the Researchers Studied
The authors reviewed synergistic Antioxidant Effects of Molecular Hydrogen and Cold Atmospheric Plasma in Enhancing Mesenchymal Stem Cell Therapy.
What Effects Did Molecular Hydrogen Have?
This review highlights the role of molecular hydrogen (H₂) and cold atmospheric plasma (CAP) as adjunct therapies to improve the effectiveness of MSC therapy. The authors concluded that in conjunction with the introduction of molecular hydrogen (H₂ ) and cold atmospheric plasma into MSC therapy, several promising research directions can be drawn forth that may considerably enhance the therapeutic efficacy of MSCs. Molecular hydrogen (H₂ ) is gaining more and more interest as a therapeutic agent due to its strong antioxidant and anti-inflammatory effects, thus making it a potentially useful additive in MSC therapy. Through better development of delivery systems, researchers may further the therapeutic benefits of MSC therapy, especially when applied in diseases where molecular hydrogen holds beneficial pro-anti-inflammatory and regenerative actions.
Why These Findings Matter
The reviewed evidence adds support for molecular hydrogen's therapeutic potential across the conditions, mechanisms, or outcomes examined.
How Strong Is This Evidence?
This is review or synthesis evidence (narrative review).
Technical Study Details
H2HUBB classifies this publication as narrative review with review or synthesis evidence. The study used a narrative review. The hydrogen delivery method was hydrogen-rich water.
Limitations and Safety
No separate limitations or safety findings were identified in the current-study source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.